SOTAC
Start SIP
Invest Now
Start SIP in SOTAC
Performance
- Low
- ₹105
- High
- ₹105
- 52 Week Low
- ₹88
- 52 Week High
- ₹152
- Open Price₹105
- Previous Close₹100
- Volume1,200
- 50 DMA₹122.35
- 100 DMA₹123.37
- 200 DMA₹124.50
Investment Returns
- Over 1 Month -14.91%
- Over 3 Month -16%
- Over 6 Month -15.32%
- Over 1 Year -3.89%
Smart Investing Starts Here Start SIP with Sotac Pharmaceuticals Ltd for Steady Growth!
Sotac Pharmaceuticals Ltd Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 14.5
- PEG Ratio
- 0.1
- Market Cap Cr
- 116
- P/B Ratio
- 2.5
- Average True Range
- 5.67
- EPS
- 6.95
- Dividend Yield
- 0.1
- MACD Signal
- -2.34
- RSI
- 36.27
- MFI
- 52.65
Sotac Pharmaceuticals Ltd Financials
Sotac Pharmaceuticals Ltd Technicals
EMA & SMA
Current Price
₹105.00
+
5
(5%)
- Bearish Moving Average 15
- Bullish Moving Average 1
- 20 Day
- ₹118.40
- 50 Day
- ₹122.35
- 100 Day
- ₹123.37
- 200 Day
- ₹124.50
Resistance and Support
105
- R3 105.00
- R2 105.00
- R1 105.00
- S1 105.00
- S2 105.00
- S3 105.00
Sotac Pharmaceuticals Ltd Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-12 | Quarterly Results & Others | To consider other business matters. Final Dividend of Rs. 0.1 per equity share. |
| 2025-05-28 | Audited Results, Dividend & Others | To consider other business matters. Final Dividend of Rs. 0.1 per equity share. |
| 2024-10-29 | Quarterly Results | |
| 2024-08-13 | Quarterly Results | |
| 2024-05-17 | Audited Results & Others | To consider other business matters Final Dividend of Rs. 0.1 per equity share. |
Sotac Pharmaceuticals Ltd F&O
About Sotac Pharmaceuticals Ltd
- NSE Symbol
- SOTAC
- BSE Symbol
- Chairman & Managing Director
- Mr. Sharadkumar Dashrathbhai Patel
- ISIN
- INE0O2D01012
Similar Stocks to Sotac Pharmaceuticals Ltd
Sotac Pharmaceuticals Ltd FAQs
Sotac Pharmaceuticals Ltd share price is ₹105 As on 24 January, 2026 | 03:28
The Market Cap of Sotac Pharmaceuticals Ltd is ₹116 Cr As on 24 January, 2026 | 03:28
The P/E ratio of Sotac Pharmaceuticals Ltd is 14.5 As on 24 January, 2026 | 03:28
The PB ratio of Sotac Pharmaceuticals Ltd is 2.5 As on 24 January, 2026 | 03:28
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.